SMT201400033B - Inibitori di cxcr1/2 come coadiuvanti nel trapianto delle isole pancreatiche - Google Patents
Inibitori di cxcr1/2 come coadiuvanti nel trapianto delle isole pancreaticheInfo
- Publication number
- SMT201400033B SMT201400033B SM201400033T SM201400033T SMT201400033B SM T201400033 B SMT201400033 B SM T201400033B SM 201400033 T SM201400033 T SM 201400033T SM 201400033 T SM201400033 T SM 201400033T SM T201400033 B SMT201400033 B SM T201400033B
- Authority
- SM
- San Marino
- Prior art keywords
- cxcr1
- adjuvants
- inhibitors
- pancreatic islet
- islet transplantation
- Prior art date
Links
- 101150013700 CXCR1 gene Proteins 0.000 title 1
- 239000002671 adjuvant Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 210000004153 islets of langerhan Anatomy 0.000 title 1
- 238000002054 transplantation Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09172364A EP2308484A1 (en) | 2009-10-06 | 2009-10-06 | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| PCT/EP2010/064921 WO2011042466A1 (en) | 2009-10-06 | 2010-10-06 | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201400033B true SMT201400033B (it) | 2014-07-07 |
Family
ID=41818891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201400033T SMT201400033B (it) | 2009-10-06 | 2014-03-19 | Inibitori di cxcr1/2 come coadiuvanti nel trapianto delle isole pancreatiche |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20120202884A1 (enExample) |
| EP (2) | EP2308484A1 (enExample) |
| JP (2) | JP5834010B2 (enExample) |
| KR (2) | KR101759362B1 (enExample) |
| CN (2) | CN104906572A (enExample) |
| AU (1) | AU2010305385B2 (enExample) |
| BR (1) | BR112012007991B8 (enExample) |
| CA (1) | CA2775902C (enExample) |
| CY (1) | CY1115018T1 (enExample) |
| DK (1) | DK2485723T3 (enExample) |
| EA (1) | EA021298B1 (enExample) |
| ES (1) | ES2451349T3 (enExample) |
| HK (1) | HK1213777A1 (enExample) |
| HR (1) | HRP20140202T1 (enExample) |
| IL (1) | IL219037A (enExample) |
| ME (1) | ME01719B (enExample) |
| MX (1) | MX2012004082A (enExample) |
| NZ (1) | NZ599172A (enExample) |
| PL (1) | PL2485723T3 (enExample) |
| PT (1) | PT2485723E (enExample) |
| RS (1) | RS53249B (enExample) |
| SI (1) | SI2485723T1 (enExample) |
| SM (1) | SMT201400033B (enExample) |
| WO (1) | WO2011042466A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2308484A1 (en) * | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
| CN103159652B (zh) * | 2011-12-19 | 2016-06-08 | 天津市国际生物医药联合研究院 | 亚磺酰胺类化合物的制备及其应用 |
| WO2014205127A2 (en) | 2013-06-18 | 2014-12-24 | New York University | Cellular factors involved in the cytotoxicity of staphylococcus aureus leukocidins: novel therapeutic targets |
| CN117503933A (zh) | 2016-10-03 | 2024-02-06 | 儿童医疗中心公司 | 糖尿病肾病的预防和治疗 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1303249B1 (it) | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| WO2001078653A2 (en) * | 2000-04-14 | 2001-10-25 | Millennium Pharmaceuticals, Inc. | Graft rejection inhibition with ccr2 inhibitors |
| AU2001253496A1 (en) * | 2000-04-14 | 2001-10-30 | Millennium Pharmaceuticals, Inc. | Treating graft rejection with cxcr3 inhibitors |
| ITMI20010206A1 (it) * | 2001-02-02 | 2002-08-02 | Dompe Spa | Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz |
| CN1934077B (zh) | 2004-03-23 | 2010-09-29 | 冬姆佩制药股份公司 | 2-苯基丙酸衍生物及含有它们的药物组合物 |
| DE602004003673T2 (de) | 2004-03-25 | 2007-10-04 | Dompe' Pha.R.Ma S.P.A. | Verwendung von N-(2-Aryl-propionyl)-sulfonamiden zur Behandlung von Rückenmarkverletzungen |
| US20050261762A1 (en) * | 2004-05-21 | 2005-11-24 | Medtronic Vascular, Inc. | Medical devices to prevent or inhibit restenosis |
| AU2005283326B2 (en) * | 2004-09-13 | 2011-07-21 | Ono Pharmaceutical Co., Ltd. | Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| EP2040690B1 (en) * | 2006-06-28 | 2014-08-06 | Sanofi | Inhibitors of cxcr2 |
| JP2010504996A (ja) * | 2006-09-26 | 2010-02-18 | ケース ウエスタン リザーブ ユニバーシティ | サイトカインシグナリング |
| KR20110014141A (ko) | 2008-03-20 | 2011-02-10 | 카롤러스 테라퓨틱스, 인코포레이티드 | 염증을 치료하는 방법 |
| EP2308484A1 (en) * | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
-
2009
- 2009-10-06 EP EP09172364A patent/EP2308484A1/en not_active Withdrawn
-
2010
- 2010-10-06 NZ NZ599172A patent/NZ599172A/en not_active IP Right Cessation
- 2010-10-06 US US13/500,544 patent/US20120202884A1/en not_active Abandoned
- 2010-10-06 KR KR1020127010732A patent/KR101759362B1/ko not_active Expired - Fee Related
- 2010-10-06 KR KR1020177015626A patent/KR101817912B1/ko not_active Expired - Fee Related
- 2010-10-06 DK DK10761018.0T patent/DK2485723T3/en active
- 2010-10-06 CA CA2775902A patent/CA2775902C/en not_active Expired - Fee Related
- 2010-10-06 ES ES10761018.0T patent/ES2451349T3/es active Active
- 2010-10-06 SI SI201030553T patent/SI2485723T1/sl unknown
- 2010-10-06 CN CN201510089937.5A patent/CN104906572A/zh active Pending
- 2010-10-06 MX MX2012004082A patent/MX2012004082A/es active IP Right Grant
- 2010-10-06 AU AU2010305385A patent/AU2010305385B2/en not_active Ceased
- 2010-10-06 RS RS20140102A patent/RS53249B/sr unknown
- 2010-10-06 WO PCT/EP2010/064921 patent/WO2011042466A1/en not_active Ceased
- 2010-10-06 JP JP2012532579A patent/JP5834010B2/ja not_active Expired - Fee Related
- 2010-10-06 BR BR112012007991A patent/BR112012007991B8/pt not_active IP Right Cessation
- 2010-10-06 PT PT107610180T patent/PT2485723E/pt unknown
- 2010-10-06 EA EA201270513A patent/EA021298B1/ru unknown
- 2010-10-06 HR HRP20140202AT patent/HRP20140202T1/hr unknown
- 2010-10-06 PL PL10761018T patent/PL2485723T3/pl unknown
- 2010-10-06 ME MEP-2014-24A patent/ME01719B/me unknown
- 2010-10-06 CN CN201080045208.5A patent/CN102665703B/zh not_active Expired - Fee Related
- 2010-10-06 EP EP10761018.0A patent/EP2485723B1/en active Active
-
2012
- 2012-04-04 IL IL219037A patent/IL219037A/en active IP Right Grant
-
2014
- 2014-03-07 CY CY20141100185T patent/CY1115018T1/el unknown
- 2014-03-19 SM SM201400033T patent/SMT201400033B/xx unknown
-
2015
- 2015-04-06 JP JP2015077750A patent/JP6097328B2/ja not_active Expired - Fee Related
-
2016
- 2016-02-18 HK HK16101720.7A patent/HK1213777A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201400116B (it) | Pirimidinoni come inibitori delle PI13K | |
| DK3037536T3 (da) | Oligonukleotiderstatning for di-taggede og retnings biblioteker | |
| SMT201500043B (it) | Indazoli ossazolo-sostituiti come inibitori di pi13-chinasi | |
| SMT201600075B (it) | Composto di diamminocarbossammide eterociclica | |
| SMT201600291B (it) | Inibitori di proteasi hcv | |
| SMT201400175B (it) | Derivati amminopropionici sostituiti come inibitori di neprilisina | |
| HUE043645T2 (hu) | Konjugációs módszerek | |
| DK2763665T3 (da) | Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf | |
| DK3583975T3 (da) | Pandehuleudvidelseskateter | |
| DK2504353T4 (da) | Lipopeptidsammensætninger og tilsvarende fremgangsmåder | |
| SMT201600076B (it) | Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo | |
| SMT201500268B (it) | Derivato di 5-idrossipirimidin-4-carbossammide | |
| SMT201400080B (it) | Derivati di pirazinoossazepina | |
| SMT201400033B (it) | Inibitori di cxcr1/2 come coadiuvanti nel trapianto delle isole pancreatiche | |
| DK2633029T3 (da) | Sammensætninger og fremgangsmåder til dyrkning af spirokæter | |
| DK2921486T3 (da) | Sammensætninger og fremgangsmåder til behandling af beta-amyloid-relaterede sygdomme | |
| DK2305069T3 (da) | Reolhylder | |
| ES1071511Y (es) | Estanteria modular | |
| SMT201300010B (it) | Derivati di piridazinoni | |
| IT1396036B1 (it) | Configurazione strutturale di campo cimiteriale | |
| ES1070826Y (es) | Mueble joyero cuelga-collares | |
| UA18828S (uk) | Шафа | |
| TH104444B (th) | ตู้ใส่เสื้อผ้า | |
| UA18829S (uk) | Шафа | |
| UA20116S (uk) | Шафа для одягу |